Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.56 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29565890 | 1.00 | KDM4E (0.56) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| Hydrochloric Acid SCHEMBL1151664 | 1.00 | KDM4E (0.56) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| SCHEMBL483710 | 0.99 | KDM4E (0.57) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| SCHEMBL3401541 | 0.99 | KDM4E (0.57) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| Hydrochloric Acid SCHEMBL4807029 | 0.84 | KDM4E (0.52) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| Hydrochloric Acid SCHEMBL4804157 | 0.84 | KDM4E (0.52) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| Hydrochloric Acid SCHEMBL4798212 | 0.84 | KDM4E (0.52) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| SCHEMBL839455 | 0.83 | KDM4E (0.42) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| SCHEMBL5195813 | 0.83 | KDM4E (0.53) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| SCHEMBL5197506 | 0.83 | KDM4E (0.53) | KDM4ENPC1PABPC1APOBEC3ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7399320-B2 | Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds | L'OREAL (FR) | 2008-07-15 | — | — | US | claimed |
| US-20080092307-A1 | Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds | L'OREAL (FR) | 2008-04-24 | — | — | US | claimed |
| EP-1548006-B1 | Synthesis of tetraazapentamethine derivatives, keratin fibers dyeing process which uses such synthesis | OREAL (FR) | 2007-09-05 | — | — | EP | claimed |
| WO-2007071685-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND ANOTHER PARTICULAR DIRECT DYE | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | claimed |
| WO-2007071686-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, AN OXIDATION BASE AND A PARTICULAR COUPLER | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | claimed |
| WO-2007071689-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND ANOTHER PARTICULAR DIRECT DYE | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | claimed |
| WO-2007071688-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, A PARTICULAR OXIDATION BASE AND A COUPLER | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | claimed |
| WO-2007071684-A2 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND AN AMINO SILICONE | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | claimed |
| WO-2007071683-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND A NONIONIC SURFACTANT | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | claimed |
| US-20050198744-A1 | Applying 2-[5-(N-methyl-2-pyridinylidene)-1-formazano]-N-methylpyridinium chloride and an oxidizing agent, developing the desired coloration | L'OREAL S.A. (FR) | 2005-09-15 | — | — | US | claimed |
| US-20050028300-A1 | Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds | L'OREAL (FR) | 2005-02-10 | — | — | US | claimed |
| US-11896700-B2 | Process for treating keratin fibers using an anhydrous composition comprising a compound of azomethine type comprising two pyrazolopyridine units and an aqueous composition | L'OREAL (FR) | 2024-02-13 | — | — | US | disclosed |
| US-20230137804-A1 | PROCESS FOR TREATING KERATIN FIBERS USING AN ANHYDROUS COMPOSITION COMPRISING A COMPOUND OF AZOMETHINE TYPE COMPRISING TWO PYRAZOLOPYRIDINE UNITS AND AN AQUEOUS COMPOSITION | L'OREAL (FR) | 2023-05-04 | — | — | US | disclosed |
| EP-3474815-B1 | PROCESS FOR TREATING KERATIN FIBERS USING AN ANHYDROUS COMPOSITION COMPRISING A COMPOUND OF AZOMETHINE TYPE COMPRISING TWO PYRAZOLOPYRIDINE UNITS AND AN AQUEOUS COMPOSITION | OREAL (FR) | 2022-03-16 | — | — | EP | disclosed |
| EP-3475278-B1 | (DIS)SYMMETRIC AZOMETHINE-TYPE DIRECT DYE COMPRISING AT LEAST ONE PYRAZOLOPYRIDINE UNIT, PROCESS FOR DYEING KERATIN FIBERS USING THIS DYE | OREAL (FR) | 2021-12-22 | — | — | EP | disclosed |
| WO-2007071685-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND ANOTHER PARTICULAR DIRECT DYE | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | disclosed |
| WO-2007071686-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, AN OXIDATION BASE AND A PARTICULAR COUPLER | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | disclosed |
| WO-2007071689-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND ANOTHER PARTICULAR DIRECT DYE | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | disclosed |
| US-20050198744-A1 | Applying 2-[5-(N-methyl-2-pyridinylidene)-1-formazano]-N-methylpyridinium chloride and an oxidizing agent, developing the desired coloration | L'OREAL S.A. (FR) | 2005-09-15 | — | — | US | disclosed |
| US-20050028300-A1 | Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds | L'OREAL (FR) | 2005-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11896700-B2 | Process for treating keratin fibers using an anhydrous composition comprising a compound of azomethine type comprising two pyrazolopyridine units and an aqueous composition | KRT18, DPYD, CKAP4 | KDM4E 801/4885NPC1 4803/4885PABPC1 2185/4885 |
| US-20050028300-A1 | Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds | KRT18, TET1, DNMT1 | KDM4E 237/4885NPC1 4628/4885PABPC1 3468/4885 |
| US-20230137804-A1 | PROCESS FOR TREATING KERATIN FIBERS USING AN ANHYDROUS COMPOSITION COMPRISING A COMPOUND OF AZOMETHINE TYPE COMPRISING TWO PYRAZOLOPYRIDINE UNITS AND AN AQUEOUS COMPOSITION | KRT18, DPYD, CKAP4 | KDM4E 801/4885NPC1 4803/4885PABPC1 2185/4885 |
| US-20050198744-A1 | Applying 2-[5-(N-methyl-2-pyridinylidene)-1-formazano]-N-methylpyridinium chloride and an oxidizing agent, developing the desired coloration | KRT18, TPM4, AZI2 | KDM4E 407/4885NPC1 4861/4885PABPC1 2982/4885 |
| US-20080092307-A1 | Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds | KRT18, TUBA4A, TUBB4A | KDM4E 154/4885NPC1 4393/4885PABPC1 2660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.